Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity

Details for Australian Patent Application No. 2003299722 (hide)

Event Publications

27 May 2004 Complete Application Filed

Priority application(s): 60/501,170 08.09.03 US; 60/510,785 08.10.03 US; 60/517,290 04.11.03 US; 60/518,812 10.11.03 US; 10/322,266 17.12.02 US; 60/493,226 07.08.03 US

19 August 2004 Application Open to Public Inspection

Published as AU-A-2003299722

30 June 2005 Amendment Made

The nature of the amendment is: Amend priority details from 60/510,785 08 Oct 2003 US to 60/510,785 10 Oct 2003 US

8 January 2009 Alteration of Name

The name of the applicant has been altered to MDRNA, Inc. 2004

16 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.